(Applicant's narrative) This application for a Community Clinical Oncology Program (CCOP) is from the Baptist Cancer Institute (BCI), a component of the Baptist Memorial Hospital and Health Care System based in Memphis, Tennessee. BCI has a clinical base of over 2,600 new cancer cases each year, and $11 million annual clinical/staff budget, and a commitment of over $3 million from the Baptist Memorial Health Care Foundation to provide supplemental funding for key personnel, space, supplies, and travel in this application. The BCI-CCOP investigators have a substantial track record of accruals to National Cancer Institute (NCI) cooperative research groups, with 226 patients on clinical research trials and 13 patients on cancer control and prevention trials over the past three years. This application formalizes affiliations with CALGB (as a University of Tennessee affiliate), NSABP, GOG, RTOG, and MDA, involving 47 investigators and proposes to accrue 108 patients to clinical trials and 68 patients to cancer prevention and control projects of these affiliates. The experienced BCI-CCOP staff and investigators, supported by substantial institutional financial commitments propose to participate with their research base in the development of and accrual to national trials; to maintain high quality standards through extensive quality assurance checking; and to continue to assure access to minority patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA071323-02
Application #
2429919
Study Section
Special Emphasis Panel (SRC (15))
Project Start
1996-09-30
Project End
1999-05-31
Budget Start
1997-06-01
Budget End
1998-05-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Baptist Memorial Hospital (Memphis, TN)
Department
Type
DUNS #
City
Memphis
State
TN
Country
United States
Zip Code
38146
Heist, Rebecca S; Wang, Xiaofei; Hodgson, Lydia et al. (2014) CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer. J Thorac Oncol 9:214-21
Jeon, Justin; Sato, Kaori; Niedzwiecki, Donna et al. (2013) Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance. Clin Colorectal Cancer 12:233-8
Ogino, Shuji; Shima, Kaori; Meyerhardt, Jeffrey A et al. (2012) Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res 18:890-900
Bertagnolli, Monica M; Redston, Mark; Compton, Carolyn C et al. (2011) Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. J Clin Oncol 29:3153-62
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (2010) Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol 28:1247-53
Ogino, Shuji; Meyerhardt, Jeffrey A; Irahara, Natsumi et al. (2009) KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803. Clin Cancer Res 15:7322-9
Bertagnolli, Monica M; Warren, Robert S; Niedzwiecki, Donna et al. (2009) p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803. Clin Cancer Res 15:2116-22
Stinchcombe, Thomas E; Hodgson, Lydia; Herndon 2nd, James E et al. (2009) Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer. J Thorac Oncol 4:1117-25
Chan, Jennifer A; Meyerhardt, Jeffrey A; Niedzwiecki, Donna et al. (2008) Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA 299:2515-23
Vokes, Everett E; Herndon 2nd, James E; Kelley, Michael J et al. (2007) Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25:1698-704

Showing the most recent 10 out of 17 publications